FDA approves device for treatment of osteoid osteoma in the extremities

FDA

27 November 2020 - The FDA approved the Sonalleve MR-HIFU system (Profound Medical) for the treatment of osteoid osteoma in the extremities.

MR-guided High Intensity Focused Ultrasound treatment is an image guided technique combining high intensity focused ultrasound ablation with real time monitoring of temperature change during the sonication.

Read FDA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , US , Device